EASEE® system study for drug-resistant epilepsy
Part of Brain & nervous system clinical trials.
This trial tests a new device called EASEE® that may help reduce seizures in adults with drug-resistant focal epilepsy. It is for people who still have at least four observable seizures a month despite taking medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with focal epilepsy that does not respond well to medication.
- You have at least four seizures a month that can be seen by someone else.
- Your epilepsy medication has been stable (no major changes recently).
- You do not have non-epileptic seizures or active generalized epilepsy.
- You are not pregnant and do not have a brain stimulation device or active vagus nerve stimulator.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of brain stimulation (temporal interference) to help reduce seizures in adults whose epilepsy has not been controlled by medication. You may be able to join if you are already scheduled for a monitoring procedure called stereo-EEG (sEEG).
This trial tests a new type of stimulation placed under the skin to help control seizures in people with epilepsy. It is for patients whose seizures are not controlled with medication and who cannot have surgery.
This trial tests a new device to help diagnose epilepsy in people whose previous EEG brain monitoring did not give clear answers. If you have drug-resistant epilepsy with at least one seizure a month on average, this study may help find better treatment options.
This study tests a new implanted device that stimulates the vagus nerve (a major nerve in your neck) to help reduce seizures in people whose epilepsy doesn't respond well to medications. The device is surgically placed under the skin and may help lower how often you have seizures.
This study tests how well a specific brain-recording device works during a procedure used to map seizure origins in people with drug-resistant, disabling focal epilepsy. It may help doctors plan treatment by improving how well they can localize the seizure focus before possible surgery.
This trial tests a treatment called 'extreme capsule electrical stimulation' for people with epilepsy that doesn't get better with medication. The goal is to see if delivering small electrical pulses to a specific brain area can reduce seizures.
Hear when a new Drug-Resistant Focal Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.